P. Gokcen And E. ALTINKAYA, "HEPATITIS B REACTIVATION RISK IN PATIENTS WITH RHEUMATOLOGIC DISEASES UNDER BIOLOGIC TREATMENT," ACTA MEDICA MEDITERRANEA , vol.37, no.3, pp.1529-1533, 2021
Gokcen, P. And ALTINKAYA, E. 2021. HEPATITIS B REACTIVATION RISK IN PATIENTS WITH RHEUMATOLOGIC DISEASES UNDER BIOLOGIC TREATMENT. ACTA MEDICA MEDITERRANEA , vol.37, no.3 , 1529-1533.
Gokcen, P., & ALTINKAYA, E., (2021). HEPATITIS B REACTIVATION RISK IN PATIENTS WITH RHEUMATOLOGIC DISEASES UNDER BIOLOGIC TREATMENT. ACTA MEDICA MEDITERRANEA , vol.37, no.3, 1529-1533.
Gokcen, Pinar, And ENGİN ALTINKAYA. "HEPATITIS B REACTIVATION RISK IN PATIENTS WITH RHEUMATOLOGIC DISEASES UNDER BIOLOGIC TREATMENT," ACTA MEDICA MEDITERRANEA , vol.37, no.3, 1529-1533, 2021
Gokcen, Pinar And ALTINKAYA, ENGİN. "HEPATITIS B REACTIVATION RISK IN PATIENTS WITH RHEUMATOLOGIC DISEASES UNDER BIOLOGIC TREATMENT." ACTA MEDICA MEDITERRANEA , vol.37, no.3, pp.1529-1533, 2021
Gokcen, P. And ALTINKAYA, E. (2021) . "HEPATITIS B REACTIVATION RISK IN PATIENTS WITH RHEUMATOLOGIC DISEASES UNDER BIOLOGIC TREATMENT." ACTA MEDICA MEDITERRANEA , vol.37, no.3, pp.1529-1533.
@article{article, author={Pinar Gokcen And author={ENGİN ALTINKAYA}, title={HEPATITIS B REACTIVATION RISK IN PATIENTS WITH RHEUMATOLOGIC DISEASES UNDER BIOLOGIC TREATMENT}, journal={ACTA MEDICA MEDITERRANEA}, year=2021, pages={1529-1533} }